Cue Health Future Growth
Future criteria checks 1/6
Cue Health is forecast to grow earnings and revenue by 30.4% and 17.1% per annum respectively. EPS is expected to grow by 35.7% per annum. Return on equity is forecast to be -76.4% in 3 years.
Key information
30.4%
Earnings growth rate
35.7%
EPS growth rate
| Medical Equipment earnings growth | 18.4% |
| Revenue growth rate | 17.1% |
| Future return on equity | -76.4% |
| Analyst coverage | Low |
| Last updated | 15 Nov 2023 |
Recent future growth updates
Recent updates
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10
These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Cue Health COVID-19 at-home, test-to-treat service launches nationwide
Aug 29Cue Health Non-GAAP EPS of -$0.37 beats by $0.09, revenue of $87.7M beats by $34.8M
Aug 10Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals
May 18Cue Health: Significant Growth Potential Looking Beyond The Pandemic
Jan 10We're Interested To See How Cue Health (NASDAQ:HLTH) Uses Its Cash Hoard To Grow
Dec 24Cue Health IPO: More Than COVID Testing
Oct 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 151 | -160 | -64 | -7 | 5 |
| 12/31/2024 | 97 | -217 | -147 | -88 | 5 |
| 12/31/2023 | 69 | -292 | -252 | -119 | 5 |
| 9/30/2023 | 199 | -257 | -189 | -161 | N/A |
| 6/30/2023 | 251 | -276 | -231 | -188 | N/A |
| 3/31/2023 | 329 | -291 | -255 | -197 | N/A |
| 12/31/2022 | 483 | -194 | -175 | -112 | N/A |
| 9/30/2022 | 529 | -138 | -142 | -51 | N/A |
| 6/30/2022 | 683 | -67 | -83 | 8 | N/A |
| 3/31/2022 | 733 | 34 | -41 | 57 | N/A |
| 12/31/2021 | 618 | 33 | -125 | -9 | N/A |
| 9/30/2021 | 439 | -11 | -16 | 134 | N/A |
| 6/30/2021 | 220 | -24 | -60 | 76 | N/A |
| 3/31/2021 | 87 | -37 | -44 | 65 | N/A |
| 12/31/2020 | 23 | -47 | 15 | 93 | N/A |
| 12/31/2019 | 7 | -21 | -16 | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HLTH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HLTH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HLTH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HLTH's revenue (17.1% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: HLTH's revenue (17.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HLTH is forecast to be unprofitable in 3 years.